HCV Genotype 1 Viral Loads Decline
September 05, 2008
A six-month follow-up to Intercell's Phase II trial of their Hepatitis C vaccine with a topical toll-like receptor agonist showed a significant reduction in viral load. While data from two weeks after the vaccination series showed promise, participants with Hepatitis C genotype 1 had viral loads that continued to decline six months after treatment.
Continue reading "HCV Genotype 1 Viral Loads Decline"
Posted by Editors at 11:01 AM
Former Anti-Itch Drug Useful Against Hep C
California scientists have found that an old antihistamine drastically reduces Hepatitis C viral replication.
Continue reading "Former Anti-Itch Drug Useful Against Hep C"
Posted by Editors at 10:52 AM
Hep C Treatment: Comparing the Pegylated Interferons
August 26, 2008
Learn about the facts on pegylated interferon alfa-2a and pegylated interferon alfa-2b, the standard treatment for chronic Hepatitis C. Comparing and contrasting the pegylated interferons may help better explain a physician’s preference or indifference between the two when treating their Hepatitis C patients.
Continue reading "Hep C Treatment: Comparing the Pegylated Interferons"
Posted by Editors at 10:52 AM
Advanced Trial Could Change Hepatitis C Treatment
August 22, 2008
Hundreds of non-responders to interferon-ribavirin combination therapy will be enrolled in a late stage clinical trial for Vertex's telaprevir.
Continue reading "Advanced Trial Could Change Hepatitis C Treatment"
Posted by Editors at 01:51 PM
Silymarin Improves Quality of Life During Hepatitis C Treatment
August 15, 2008
Although a large-scale study concluded long-term interferon therapy to be ineffectual for Hepatitis C management, it demonstrated improvements in quality of life for participants supplementing with silymarin.
Continue reading "Silymarin Improves Quality of Life During Hepatitis C Treatment"
Posted by Editors at 03:05 PM
Early Hepatitis C Treatment Increases Success
August 12, 2008
Currently approved treatment for chronic Hepatitis C is about 50 percent effective. New research from Canada claims that early treatment boosts its effectiveness up to 90 percent.
Continue reading "Early Hepatitis C Treatment Increases Success"
Posted by Editors at 10:16 AM
Popular Blood Thinner May Reduce Liver Scarring for HCV Patients
Successful animal studies have paved the way for a human trial to determine if warfarin prevents liver damage in those with Hepatitis C.
Continue reading "Popular Blood Thinner May Reduce Liver Scarring for HCV Patients"
Posted by Editors at 10:12 AM
R1626 Could Help Defeat Hepatitis C
August 05, 2008
Whether added to standard combination therapy or as a monotherapy, studies show that R1626 is a powerful HCV anti-viral medicine.
Continue reading "R1626 Could Help Defeat Hepatitis C"
Posted by Editors at 11:14 AM
Diabetes Prevention a Priority with Hep C
July 31, 2008
Diet and exercise are often quoted as the solution to most of our modern health problems. For reducing the risk of developing liver cancer, new research shows that these lifestyle changes are crucial to people with chronic Hepatitis C.
Continue reading "Diabetes Prevention a Priority with Hep C"
Posted by Editors at 03:33 PM
Two Promising Ways to Quit Alcohol
July 29, 2008
In addition to cutting the risk for fatty liver disease, research presented at the Research Society on Alcoholism conference confirmed two distinct approaches that can help those battling alcoholism.
Continue reading "Two Promising Ways to Quit Alcohol"
Posted by Editors at 04:07 PM
Liver Donor Pool Expands For Hepatitis C Patients
Learn about the discovery made by St. Louis researchers that will expand the liver donor pool for HCV patients, and find out if Hepatitis C serology affects post-liver transplant survival rate.
Continue reading "Liver Donor Pool Expands For Hepatitis C Patients"
Posted by Editors at 03:48 PM
Natalie Cole Optimistic About Her Battle with Hepatitis C
July 21, 2008
Although currently recovering from combination therapy's side effects, the well-respected vocalist Natalie Cole may have conquered the Hepatitis C virus.
Continue reading "Natalie Cole Optimistic About Her Battle with Hepatitis C"
Posted by Editors at 10:06 AM
Hep C and Fatty Liver Disease Linked
July 09, 2008
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease.
Continue reading "Hep C and Fatty Liver Disease Linked"
Posted by Editors at 03:29 PM
Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated with ANA773 are about to begin in the Netherlands.
Continue reading "Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands"
Posted by Editors at 03:23 PM
Popular Illegal Drug Extra Harmful with HCV
July 07, 2008
Scientists have found a popular street drug worsens Hepatitis C infection in two worrisome ways.
Continue reading "Popular Illegal Drug Extra Harmful with HCV"
Posted by Editors at 12:19 PM
Hep C Long-Term Management Strategies
Since only about half of those on combination therapy beat Hepatitis C, the remaining people must strive to prevent their liver disease from progressing. Thus far, a liver wellness approach is a safer, more effective way to remain healthy compared to long-term interferon therapy.
Continue reading "Hep C Long-Term Management Strategies"
Posted by Editors at 12:00 PM
Good News for Non-Responders to HCV Combination Therapy
June 27, 2008
A Phase 3 trial evaluating ZADAXIN® (thymalfasin) as a potential third component for Hepatitis C traditional combination therapy has just been completed. Although the data is currently being analyzed and won't be available until later in the year, the lead investigator anticipates good news for previous non-responders.
Continue reading "Good News for Non-Responders to HCV Combination Therapy"
Posted by Editors at 10:35 AM
Purer, Less Costly Interferon for Hepatitis C and B Treatment
June 23, 2008
The Taiwan-based biopharmaceutical company PharmaEssentia Corp. is testing P1101, its third-generation PEG-interferon-alpha drug candidate. Because it is a longer-lasting, purer interferon that is less costly to produce, P1101 could enhance the treatment options for Hepatitis C and B.
Continue reading "Purer, Less Costly Interferon for Hepatitis C and B Treatment"
Posted by Editors at 02:35 PM
New Technology May Help Treat Hepatitis
While pharmaceutical companies are racing to find safer, more effective treatments for viral Hepatitis C and B, physicists from Arizona have a unique perspective on accomplishing the same goal. Learn how these scientists believe the virus could be rendered harmless with this non-traditional, non-invasive procedure.
Continue reading "New Technology May Help Treat Hepatitis"
Posted by Editors at 02:12 PM
Alcoholism and Viral Hepatitis
Conquering viral hepatitis is hard enough without the added challenge of alcoholism. The drug gabapentin as a treatment for alcohol dependence is currently being evaluated in human trials.
Continue reading "Alcoholism and Viral Hepatitis"
Posted by Editors at 02:04 PM
HCV Treatment Success: Early Response vs. Genotype
June 11, 2008
As presented at the April 2008 meeting of the European Association for the Study of the Liver, a rapid virological response can help clinicians customize the length of treatment for Hepatitis C – regardless of genotype.
Continue reading "HCV Treatment Success: Early Response vs. Genotype"
Posted by Editors at 12:26 PM
Fatty Liver Disease is a Major Health Concern
June 10, 2008
This liver disorder is incredibly common and its progression to a serious disease is usually preventable.
Continue reading "Fatty Liver Disease is a Major Health Concern"
Posted by Editors at 02:29 PM
HCV Viral Load Reduced in Phase I/II Trial
Given to those already infected with Hepatitis C, ChronVac-C® is designed to boost the immune response against the virus. Preliminary trial results report a decrease in viral load of over 95 percent in the first patient to complete ChronVac-C® therapy.
Continue reading "HCV Viral Load Reduced in Phase I/II Trial"
Posted by Editors at 02:24 PM
New Breakthrough Could Prevent Hepatitis C Replication
June 06, 2008
Inspired by a pharmaceutical prototype to stop bovine viral diarrhea virus, Immtech reveals that one of their compounds may inhibit Hepatitis C's entry into human cells.
Continue reading "New Breakthrough Could Prevent Hepatitis C Replication"
Posted by Editors at 05:24 PM
Marijuana Use Sparks Liver Transplant Controversy
June 02, 2008
Despite its legality in 12 states, learn why medical marijuana use may render a person with Hepatitis C ineligible for a liver transplant.
Continue reading "Marijuana Use Sparks Liver Transplant Controversy"
Posted by Editors at 11:28 AM
Optimism Swells After Liver Conference
May 30, 2008
Several researchers at the May 2008 Digestive Disease Week in San Diego reported encouraging progress in their mission to extinguish liver disease. One of the advancements announced includes monitoring dendritic cells to determine which Hepatitis C patients will fare well during treatment.
Continue reading "Optimism Swells After Liver Conference"
Posted by Editors at 02:40 PM
HCV Cure Associated with Early Drop in Viral Load
Australian researchers find that the suppression of Hepatitis C viral load within the first month of beginning treatment is a good predictor of defeating the virus - regardless of co-infection with HIV.
Continue reading "HCV Cure Associated with Early Drop in Viral Load"
Posted by Editors at 02:37 PM
Wine and Liver Health
May 27, 2008
Although a study emerging from San Diego claims that a small amount of wine may protect the liver, the researchers admit that this is not true for those already living with liver disease. In fact, there are several more caveats to this surprising claim.
Continue reading "Wine and Liver Health"
Posted by Editors at 02:15 PM
What You Must Know About Alcoholic Hepatitis
May 14, 2008
If you think one must be a heavy drinker to suffer from this condition, you ought to read this article. Discover the causes, risk factors and complications of alcoholic hepatitis. Share this information with others. After reading this, anyone with liver concerns may want to abandon intoxicating beverages altogether.
Continue reading "What You Must Know About Alcoholic Hepatitis"
Posted by Editors at 09:25 AM
15 Tips for Managing Interferon-Ribavirin Side Effects
May 13, 2008
Many people abandon this challenging HCV treatment mid-course. Here are 15 ways to help manage the side effects of Hepatitis C combination therapy, to help patients' likelihood of completing the extremely challenging treatment. Share this article among patients contemplating and/or already undergoing chemotherapy for Hepatitis C, so they can help increase their likelihood of conquering the virus.
Continue reading "15 Tips for Managing Interferon-Ribavirin Side Effects"
Posted by Editors at 11:12 AM
New Mexico Offers Free Hepatitis C Hotline
May 12, 2008
Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about Hepatitis C can get some confidential, practical, expert advice.
Continue reading "New Mexico Offers Free Hepatitis C Hotline"
Posted by Editors at 12:52 PM